Clinical profile and outcomes of hepatocellular carcinoma in primary Budd-Chiari syndrome

doi:10.4251/wjgo.v16.i3.699

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2018)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-6) series.

Item

Count

PDF

WORD

HTML

1097

Figures (1-4)

149

Tables (1-6)

192

Sum=1495

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

337

Sum=436

Mar 15, 2024 (publication date) through Nov 22, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastrointest Oncol. Mar 15, 2024; 16(3): 699-715
Published online Mar 15, 2024. doi: 10.4251/wjgo.v16.i3.699

Table 3 Management of patients with Budd-Chiari syndrome at first presentation

Age	Sex	Site of obstruction	Length of block	BCS management	AFP	BCLC	CTP	HCC initial management	HCC response	Survival after HCC diagnosis in d	No. of lesions/size in cm	Reinterventions for HCC
35	M	IVC + HV	Long	IVC + HV angioplasty	115	A	A	TACE	PR	680	1 (10 cm × 10 cm)	1, TACE
38	F	HV	Long	HV angioplasty	239	B	A	TACE	PR	1656	2.0 (5.5 cm × 5.5 cm)	4, TACE, followed by TKI
37	M	IVC	Short	IVC angioplasty	17943	C (lung metastasis)	A	TACE	NA	39	1 (> 10 cm)	-
30	F	IVC	Short	IVC angioplasty	11430	B	A	TACE	PR	1280	2 (5.2 cm × 5.4 cm)	-
17	F	IVC + HV	Long	TIPSS	34930	B	A	TACE	PR	500	4 (4 cm × 5 cm)	2, TACE
38	F	HV	Long	Medical management	5905	C (PVT)	B	SC	NA	93	NA	-
52	M	HV	Long	Medical management	237	A	A	SC	NA	158	1.0 (1.6 cm × 1.8 cm)	-
22	F	IVC + HV	Long	Medical management	56804	C (PVT)	A	SC	NA	14	1 (11 cm × 11 cm)	-
48	M	HV	Long	Medical management	NA	A	A	SC	NA	5¹	1 (2.5 cm × 3.0 cm)	-
26	M	IVC + HV	Long	IVC angioplasty	15314	A	A	TACE	PD	172	1 (2.5 cm × 3.5 cm)	TKI
30	F	IVC + HV	Long	Medical management	31068	C (PVT)	B	TKI	NA	21¹	Infiltrative	-
63	M	IVC	Short	IVC angioplasty	20312	C (Rt. PVT)	A	TARE	NA	488¹	3 (> 5 cm)	-
32	F	IVC + HV	Long	IVC angioplasty	3153	B	A	TACE	CR	229¹	Multiple (2.9 cm × 2.8 cm)	1, TACE
32	M	IVC + HV	Long	IVC angioplasty	13211	C (Lt. PVT)	A	TACE	PD	240	3.0 (12.0 cm × 5.6 cm)	-
25	F	HV	Short	HV angioplasty	16.6	B	B	TACE	NA	402¹	2.0 (5.0 cm × 3.3 cm)	-
29	F	IVC + HV	Long	IVC + HV angioplasty	13029	C (PVT)	B	TKI	NA	523	1.0 (9.5 cm × 7.1 cm)	-
21	F	HV	Long	TIPSS	500	B	A	SC	NA	9¹	2 (6 cm × 8 cm)	-
33	F	IVC + HV	Long	Medical management	14308	B	B	SC	NA	97¹	2.0 (6.9 cm × 5.4 cm)	-

¹Alive at last follow up. AFP: Alpha-fetoprotein; BCLC: Barcelona Clinic Liver Cancer; BCS: Budd-Chiari syndrome; CR: Complete response; CTP: Child Turcotte Pugh; F: Female; HCC: Hepatocellular carcinoma; HV: Hepatic vein; IVC: Inferior vena cava; Lt.: Left; M: Male; NA: Not available; PD: Progressive disease; PR: Partial response; PVT: Portal vein thrombosis; Rt.: Right; SC: Supportive care; TACE: Transarterial chemoembolization; TARE: Transarterial radioembolization; TIPSS: Transjugular intrahepatic portosystemic shunt; TKI: Tyrosine kinase inhibitor.

Citation: Agarwal A, Biswas S, Swaroop S, Aggarwal A, Agarwal A, Jain G, Elhence A, Vaidya A, Gupte A, Mohanka R, Kumar R, Mishra AK, Gamanagatti S, Paul SB, Acharya SK, Shukla A, Shalimar. Clinical profile and outcomes of hepatocellular carcinoma in primary Budd-Chiari syndrome. World J Gastrointest Oncol 2024; 16(3): 699-715
URL: https://www.wjgnet.com/1948-5204/full/v16/i3/699.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i3.699